Healthcare Innovation and Evaluation
The Healthcare Innovation and Evaluation is an interdisciplinary research unit of The George Institute at the Oxford Martin School and was established in 2010 by Kazem Rahimi. The aim of the unit is to conduct high impact research to advance our understanding of common chronic diseases, to investigate how they are currently managed in clinical practice and how their management at individual and population level could be further improved. The main clinical emphasis of the programme is on cardiometabolic risk factors and conditions such as hypertension, diabetes, ischaemic heart disease, stroke, heart failure, atrial fibrillation, and vascular dementia.
The research projects within this unit seek to address three key inter-related research questions:
- What are the patterns of care practices for prevention and management of serious health events?
- Can the use of innovative health technologies and strategies help improve prevention and management of chronic diseases?
- In areas where our knowledge of effective interventions or disease mechanisms are insufficient or inaccurate, can we use the growing amount of data to better classify diseases and patient groups for more targeted interventions and stratified management?
The research methods in the Healthcare Innovation and Evaluation unit are based on epidemiology, statistics and clinical medicine, which are combined with methodologies from other disciplines such as data science, engineering and social sciences to tackle some of the most challenging healthcare problems of the 21 century.